| abstract |
The invention provides compositions and methods for the prophylactic or therapeutic treatment of amyloidogenic diseases of the eye including the optic nerve. Such methods comprise administering a therapeutic agent that reduces or eliminates optic amyloid deposits. The methods are especially useful for the therapeutic intervention and prophylaxis of Age-Related Maculopathy (ARM), Age-Related Macular Degeneration (ARMD), or Glaucomatous Optic Neuropathy (GON). |